The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Ltd

BSE 544445 · NSE APL · ISIN INE0SJX01015 · Group M · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹115.90

+9.92%

BSE close, 28 August 2026

Market cap

₹98.66 cr

0.9 cr shares · Micro cap

Free float

₹25.97 cr

as published

P/E · P/B

190.0× · —

EPS ₹0.61 · BV —

FY25-26 rev / PAT

25.47 / 3.87

₹ cr, as filed

Filings, window

20

3 selected · 15%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹60.00 52-WK HIGH ₹117.00 ₹115.90 98% of range
Against 52-week high-0.9%
Against 52-week low+93.2%
Day change+9.92%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.61
Price / earnings190.00×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 10.05 0.48 1.14 18.21% 4.80%
Sep-25 · Q 15.42 0.03 0.05 2.41% 0.22%
FY25-26 25.47 3.87 4.92 21.80% 15.18%

Quarter on quarter

Revenue, quarter on quarter
-34.8%
Net profit, quarter on quarter
+1,500.0%
Operating margin, quarter on quarter
+1,580 bps

Disclosure profile 20 filings in the window

0 median 17.0 p75 · 25 sector max 52 20 60th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management2
Board Outcome1
Selected sub-total3
Procedural
AGM / EGM6
SAST4
Auditor Appointment2
Board Meeting2
Annual Report1
Meeting Update1
Record Date1
Procedural sub-total17
Total20

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

20 filings · 3 selected · busiest 2026-09-04

Filing rhythm · the twelve most recent

2026-09-042026-10-06

SelectedProcedural

Filings

20 in the window · 10 earlier on record

  1. 6 October 2026 ·

    Board Meeting

    Board Meeting Intimation for To Consider And Approve The Following Matters As Attached

    Asston Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached

    Board Meeting / Board Meeting View filing →

  2. 1 October 2026 ·

    Change in Management

    Change in Management

    Change in Management

    Company Update / Change in Management View filing →

  3. 1 October 2026 ·

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Appointment of Statutory Auditor of the Company

    Company Update / Appointment of Statutory Auditor/s View filing →

  4. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer Report

    AGM/EGM / AGM View filing →

  5. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 7th Annual General Meeting

    AGM/EGM / AGM View filing →

  6. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  7. 7 September 2026 ·

    AGM / EGM

    Notice Of 7Th Annual General Meeting

    Notice of 7th Annual General Meeting scheduled to be held on 29th September, 2026 at 12:30 P.M.

    AGM/EGM / AGM View filing →

  8. 4 September 2026 ·

    Record Date

    Fixing Record Date

    Fixing Record date/Cut-off date to determine eligible shareholders for the E-voting facility for the 7th Annual General Meeting of the Company

    Corp. Action / Record Date View filing →

  9. 4 September 2026 ·

    AGM / EGM

    Fixing 29Th September 2026 As The Date For Convening The 7Th Annual General Meeting Of The Company.

    Fixing 29th September, 2026, as the date for convening the 7th Annual General Meeting of the Company.

    AGM/EGM / AGM View filing →

  10. 4 September 2026 ·

    Meeting Update

    Meeting Updates

    Meeting Update

    Company Update / Meeting Updates View filing →

  11. 4 September 2026 ·

    Change in Management

    Change in Management

    Change in Management

    Company Update / Change in Management View filing →

  12. 4 September 2026 ·

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Appointment of Statutory Auditor

    Company Update / Appointment of Statutory Auditor/s View filing →

  13. 4 September 2026 ·

    Board Outcome

    Board Meeting Outcome for Out Come Of The Board Meeting

    Outcome of the Board Meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  14. 4 September 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  15. 2 September 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  16. 1 September 2026 ·

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  17. 31 August 2026 ·

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  18. 27 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Convening 7Th Annual General Meeting Of The Company

    Asston Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. Appointment of M/s ....

    Board Meeting / Board Meeting View filing →

  19. 3 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM

    AGM/EGM / EGM View filing →

  20. 31 July 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of EGM

    Outcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27, scheduled to be held on 31st July, 2026, at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.

    AGM/EGM / EGM View filing →

RSS feed for Asston Pharmaceuticals Ltd · the 50 most recent filings